LENSAR, Inc. , a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
Lensar stock last closed at $2.33, down 0.85% from the previous day, and has decreased 67.41% in one year. It has underperformed other stocks in the Medical Devices industry by 0.48 percentage points. Lensar stock is currently +8.37% from its 52-week low of $2.15, and -73.52% from its 52-week high of $8.80.
There are currently 11.1M LNSR shares outstanding. The market value of LNSR is $25.87M. In the last 24 hours, 21,352 LNSR shares were traded.
You need an online brokerage account to access the NASDAQ market and buy LNSR stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro today.Open eToro Account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in LNSR stock today.
Now that you've opened your account on the best stock app for beginners, you can securely and quickly fund your account:
Check out the tutorial below if you need help depositing funds into your investment account.
Once you have identified the best place to buy Lensar stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk and upside.
WallStreetZen was created to help part-time investors perform better fundamental analysis.
You can see all of the due diligence checks on LNSR's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge LNSR's intrinsic value.
Using relative valuations methods:
You can do additional valuation analysis on LNSR's stock here.
Out of 1 sell side analysts who give recommendations on LNSR, the consensus analyst rating on Lensar is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Lensar stock forecast page.
Last year, LNSR revenue was $35.36M. Over the last 4 year, LNSR's revenue has increased by 9.73% per year. This was slower than the Medical Devices industry average of 17.51%.
You can analyze LNSR's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at LNSR have bought more shares than they have sold.
Thomas R. Staab Ii, Chief Financial Officer of LNSR, was the latest LNSR insider to buy. They bought $2,294.41 worth of LNSR stock on Dec 7, 2022.
Dig into more about who owns LNSR shares here.
No, Lensar doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two main options:
Click the Open button and your broker will place the order.
If you want more help with buying stocks on eToro, watch the helpful video below:
Now that you own some LNSR stock, you'll want to stay up-to-date on your company.
Put LNSR on a watchlist to monitor your LNSR stock.
To summarize, here are the 6 steps to buy Lensar stock:
If you are looking for a brokerage account, eToro is our recommended option.Get Started with eToro Today
If you would like to get the latest news on your investment in Lensar, click below.
How much does it cost to buy one Lensar share?
Is now a good time to buy Lensar stock?
What is the best way to buy Lensar stock?